Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Skin to Skin”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01597245
What this trial is testing

Study in Participants With Moderate to Severe Psoriasis (UNCOVER-2)

Who this might be right for
Psoriasis
Eli Lilly and Company 1,224
Post-approval studies (Phase 4)Study completedNCT01084577
What this trial is testing

AQUACEL® Ag Dressing and Urgotul® Silver Dressing on Healing of Chronic Venous Leg Ulcers

Who this might be right for
Leg Ulcer
ConvaTec Inc. 266
Early research (Phase 1)Study completedNCT02482532
What this trial is testing

Vaccine Enriched, Autologous, Activated T-Cells Directed to Tumor in Patients With Relapsed/Refractory Melanoma

Who this might be right for
Melanoma
Gary Doolittle 7
Not applicableStudy completedNCT05641168
What this trial is testing

A Pilot Evaluation Exploring New Adhesive Materials and Their Ability to Adhere to Abdominal and Peristomal Skin

Who this might be right for
Skin Abnormalities
Coloplast A/S 114
Large-scale testing (Phase 3)Study completedNCT01408550
What this trial is testing

Phase III Clinical Trial of NPB-01 in Patients With Bullous Pemphigoid Unresponsive to Corticosteroids

Who this might be right for
Bullous Pemphigoid
Nihon Pharmaceutical Co., Ltd 56
Testing effectiveness (Phase 2)WithdrawnNCT06473974
What this trial is testing

Open-label, Single-arm, Proof of Concept Study in Subjects with Mild-to-moderate Facial Hyperpigmentation

Who this might be right for
Facial Hyperpigmentation
Kayuraeffect, LLP
Not applicableStudy completedNCT02440620
What this trial is testing

Cardiac Toxicity in Medical Treatment of Breast Cancer

Who this might be right for
Heart FailureBreast Cancer
Odense University Hospital 45
Early research (Phase 1)Study completedNCT01812382
What this trial is testing

Retapamulin Microdialysis Feasibility Study

Who this might be right for
Skin Infections, Bacterial
GlaxoSmithKline 3
Early research (Phase 1)Study completedNCT06156280
What this trial is testing

A Clinical Study of TQH2929 in Healthy Adult Subjects

Who this might be right for
Psoriasis
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. 40
Testing effectiveness (Phase 2)UnknownNCT04502680
What this trial is testing

Maintenance Treatment With Eribulin Mesylate Versus Observation in Triple Negative Breast Cancer Patients

Who this might be right for
Triple Negative Breast Cancer
The First Affiliated Hospital with Nanjing Medical University 100
Post-approval studies (Phase 4)Ended earlyNCT00363688
What this trial is testing

Treating Patients With a History of Non-Life Threatening Allergic Reaction to Penicillin With Penicillin

Who this might be right for
Penicillin Allergy
Meir Medical Center
Not applicableNo Longer AvailableNCT04564755
What this trial is testing

Abrocitinib Expanded Access Protocol in Adolescents and Adults With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Pfizer
Testing effectiveness (Phase 2)Looking for participantsNCT07010835
What this trial is testing

Study of YK012 in Moderate to Severe Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus (SLE)
Excyte Biopharma Ltd 189
Not applicableWithdrawnNCT04950374
What this trial is testing

A Clinical Trial to Evaluate the Safety and Efficacy of a Moisturizer Body Lotion and a Lip Moisturizer in Adults of Atopic Dermatitis.

Who this might be right for
Atopic Dermatitis
Johnson & Johnson Consumer Inc. (J&JCI)
Testing effectiveness (Phase 2)Ended earlyNCT03831191
What this trial is testing

LY3375880 in Adults With Moderate-to-Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Eli Lilly and Company 136
Not applicableStudy completedNCT03076918
What this trial is testing

Evaluating the Device FLEXITHERALIGHT Compared to the Conventional Photodynamic Therapy

Who this might be right for
Keratosis, Actinic
University Hospital, Lille 29
Not applicableAvailableNCT04159597
What this trial is testing

Expanded Access to Upadacitinib

Who this might be right for
Crohn DiseaseUlcerative ColitisIdiopathic Arthritis (Including sJIA, pJIA, or JPsA)+11 more
AbbVie
Early research (Phase 1)Study completedNCT01428297
What this trial is testing

A Study Evaluating the Safety and Efficacy of Topical BPR277 for the Treatment of Atopic Dermatitis and Netherton Syndrome

Who this might be right for
Healthy VolunteersAtopic DermatitisNetherton Syndrome
Novartis Pharmaceuticals 12
Testing effectiveness (Phase 2)Study completedNCT00411424
What this trial is testing

Safety, Tolerability and Efficacy Study of the New Medication ASK8007 to Treat Patients With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Astellas Pharma Inc 54
Testing effectiveness (Phase 2)Study completedNCT03288324
What this trial is testing

Open-label Study of Tofacitinib for Moderate to Severe Skin Involvement in Young Adults With Lupus

Who this might be right for
Cutaneous LupusSystemic Lupus Erythematosus
Children's Hospital Medical Center, Cincinnati 13
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation